A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSE(S) OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2

Administered By

Duke Human Vaccine Institute

Awarded By

Pfizer, Inc.

Contributors

Walter Jr., Emmanuel Benjamin Principal Investigator

Start/End

June 9, 2021 - June 8, 2023